A bicenter study on adjuvant surgery following treatment with tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A bicenter study on adjuvant surgery following treatment with tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma

Published:2018-04-16 Issue:4 Volume:27 Page:598-601
ISSN:1569-9293
Container-title:Interactive CardioVascular and Thoracic Surgery
language:en
Short-container-title:

Author:

Fournel Ludovic¹,Falcoz Pierre-Emmanuel²,Mansuet-Lupo Audrey³,Garelli Elena¹,Lococo Filippo⁴,Alifano Marco¹

Affiliation:

1. Department of Thoracic Surgery, Cochin-Hospital, APHP, Paris-Descartes University, Paris, France

2. Department of Thoracic Surgery, Nouvel-Hôpital Civil, Strasbourg, France

3. Department of Pathology, Cochin-Hospital, APHP, Paris-Descartes University, France

4. Department of Thoracic Surgery, Arcispedale Santa-Maria-Nuova, Reggio-Emilia, Italy

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Link

http://academic.oup.com/icvts/article-pdf/27/4/598/25828077/ivy120.pdf

Reference11 articles.

1. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

2. Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy;Liao;Lung Cancer,2017

3. Surgical resection after gefitinib treatment in patients with lung adenocarcinoma harboring epidermal growth factor receptor gene mutation;Takamochi;Lung Cancer,2007

4. Is salvage surgery for recurrent non-small-cell lung cancer after definitive non-operative therapy associated with reasonable survival?;Schreiner;Interact CardioVasc Thorac Surg,2015

5. Salvage surgery for advanced non-small cell lung cancer after response to gefitinib;Hishida;J Thorac Cardiovasc Surg,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results;Clinical Lung Cancer;2023-07

2. The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort study;Scientific Reports;2022-12-29

3. Prise en charge chirurgicale du cancer bronchique non à petites cellules opérable : vers de nouveaux paradigmes;Bulletin du Cancer;2020-09

4. Lung resection and immunotherapy: two allied for a new hope in lung cancer cure;Journal of Thoracic Disease;2018-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3